Associations Between Donor-derived Cell-free DNA Dynamics and Clinical Outcomes After Kidney Allograft Rejection: A Prospective, Multi-center Study

By afschroeder • July 27, 2025

Bunnapradist S, Leca N, Zaky ZS, Stratta RJ, Khamash HA, Shihab F, Ekwenna O, Aldana-Campos M, Kahwaji J, Biancone L, Maw TT, Biagini DG, Kaur N, Prewett A, Gude G, Van Hummelen P, Bloom MS, Demko Z, Rabinowitz M, Chapman SL, Gauthier P, Bhorade S, Tabriziani H, Qazi Y; PEDAL investigators (Table S1). Associations Between Donor-derived Cell-free DNA Dynamics and Clinical Outcomes After Kidney Allograft Rejection: A Prospective, Multi-center Study. Am J Transplant. 2025 Jul 23:S1600-6135(25)02849-7. doi: 10.1016/j.ajt.2025.07.2470. Epub ahead of print. PMID: 40712889.

Tags: biopsy proven rejection, Clinical outcomes, dd-cfDNA, Nephrology, Publications

Heavy Chains, Heavy Consequences: A Case of Concomitant Heavy Chain Amyloidosis and Heavy Chain Deposition Disease

Amoh BK, Ghanem G, Zuckerman JE, Bruss Z, Chuang K. Heavy Chains, Heavy Consequences: A Case of Concomitant Heavy Chain Amyloidosis and Heavy Chain Deposition[...]

L-arginine Results in an Artificial Increase in Creatinine

Hwang M, Han J, Lei S, Kagan I. L-arginine Results in an Artificial Increase in Creatinine. Cureus. 2025 Oct 5;17(10):e93866. doi: 10.7759/cureus.93866. PMID: 41194845; PMCID:[...]

The sigma1 receptor is a target for the development of cardioprotective drugs

Maslov LN, Tsirulnikov K, Slidnevskaya AS, Kilin M, Kan A, Grab AE, Gorbunov AS, Singh N. The σ1receptor is a target for the development of[...]